NYSE:PRGO - Perrigo Stock Price, Price Target & More

$82.72 -0.05 (-0.06 %)

(As of 04/19/2018 03:25 PM ET)

Previous Close$82.77

Today's Range$81.68 - $82.95

52-Week Range$63.68 - $95.93

Volume475,805 shs

Average Volume1.01 million shs

Market Capitalization$11.62 billion

P/E Ratio16.76

Dividend Yield0.92%

Beta0.76

About Perrigo (NYSE:PRGO)

Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products worldwide. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments. It offers OTC products in cough, cold, allergy, sinus, analgesic, gastrointestinal, smoking cessation, infant formula and food, animal health, diagnostic, lifestyle, personal care and derma-therapeutics, natural health and vitamins, and anti-parasite categories. The company also develops, manufactures, and markets a portfolio of generic prescription drugs, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, powders, controlled substances, injectables, hormones, oral solid dosage forms, and oral liquid formulations. In addition, it offers contract manufacturing services. The company offers its products through retail drug, supermarket, and mass merchandise chains; hospitals; pharmacies; wholesalers; drug and grocery stores; and para pharmacies, as well as through a network of pharmacy sales force in North America, Europe, Australia, Israel, and China. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Receive PRGO News and Ratings via Email

Sign-up to receive the latest news and ratings for PRGO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations

Sub-IndustryPharmaceuticals

SectorMedical

SymbolNYSE:PRGO

CUSIP71429010

Webwww.perrigo.com

Phone353-1709-4000

Debt

Debt-to-Equity Ratio0.53%

Current Ratio1.96%

Quick Ratio1.40%

Price-To-Earnings

Trailing P/E Ratio16.76

Forward P/E Ratio15.82

P/E Growth2.05

Sales & Book Value

Annual Sales$4.95 billion

Price / Sales2.36

Cash Flow$8.0155 per share

Price / Cash10.32

Book Value$43.81 per share

Price / Book1.89

Profitability

EPS (Most Recent Fiscal Year)$4.93

Net Income$119.60 million

Net Margins2.42%

Return on Equity11.54%

Return on Assets5.71%

Miscellaneous

Employees10,400

Outstanding Shares140,830,000

How to Become a New Pot Stock Millionaire

Perrigo (NYSE:PRGO) Frequently Asked Questions

What is Perrigo's stock symbol?

Perrigo trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRGO."

How often does Perrigo pay dividends? What is the dividend yield for Perrigo?

Perrigo declared a quarterly dividend on Thursday, February 15th. Investors of record on Friday, March 2nd will be paid a dividend of $0.19 per share on Tuesday, March 20th. This represents a $0.76 annualized dividend and a yield of 0.92%. The ex-dividend date is Thursday, March 1st. This is an increase from Perrigo's previous quarterly dividend of $0.16. View Perrigo's Dividend History.

How were Perrigo's earnings last quarter?

Perrigo (NYSE:PRGO) announced its earnings results on Thursday, March, 1st. The company reported $1.28 earnings per share for the quarter, topping the consensus estimate of $1.25 by $0.03. The firm earned $1.28 billion during the quarter, compared to analysts' expectations of $1.26 billion. Perrigo had a net margin of 2.42% and a return on equity of 11.54%. The firm's quarterly revenue was down 3.6% on a year-over-year basis. During the same period in the previous year, the company earned $1.24 earnings per share. View Perrigo's Earnings History.

When is Perrigo's next earnings date?

Perrigo is scheduled to release their next quarterly earnings announcement on Tuesday, May, 29th 2018. View Earnings Estimates for Perrigo.

What guidance has Perrigo issued on next quarter's earnings?

Perrigo issued an update on its FY18 earnings guidance on Thursday, March, 1st. The company provided earnings per share guidance of $5.05-5.45 for the period, compared to the Thomson Reuters consensus estimate of $5.31. The company issued revenue guidance of $5-5.1 billion, compared to the consensus revenue estimate of $5.02 billion.

What price target have analysts set for PRGO?

18 Wall Street analysts have issued 12 month price objectives for Perrigo's shares. Their predictions range from $67.00 to $117.00. On average, they expect Perrigo's stock price to reach $91.8824 in the next twelve months. View Analyst Ratings for Perrigo.

What are Wall Street analysts saying about Perrigo stock?

Here are some recent quotes from research analysts about Perrigo stock:

1. Cantor Fitzgerald analysts commented, "The CDC today released updated data on the 2017-2018 Influenza Season for Week 2, ending 01/13/18 (https://www.cdc.gov/flu/weekly/)." (1/19/2018)
2. Canaccord Genuity analysts commented, "Date and time of first dissemination: May 22, 2017, 23:13 ET Date and time of production: May 22, 2017, 22:26 ET Target Price / Valuation Methodology: Perrigo Company – PRGO Discounted cash flow analysis supports an $86 valuation for PRGO shares Our discounted cash flow (DCF) analysis leads us to a price target of $86/share for PRGO. Our DCF considers our estimates through 2021, low-single-digit growth through 2033 and zero terminal growth thereafter. In addition, we expect Perrigo’s margin structure to remain somewhat consistent with our 2021 estimates." (5/22/2017)

Who are some of Perrigo's key competitors?

Some companies that are related to Perrigo include Mylan (MYL), Teva Pharmaceutical Industries (TEVA), UCB (UCBJF), Nektar Therapeutics (NKTR), BioMarin Pharmaceutical (BMRN), Grifols (GRFS), Genmab As (GNMSF), Alnylam Pharmaceuticals (ALNY), Jazz Pharmaceuticals (JAZZ), BeiGene (BGNE), SAGE Therapeutics (SAGE), Alkermes (ALKS), Valeant Pharmaceuticals International (VRX), Catalent (CTLT), Ionis Pharmaceuticals (IONS), Dr. Reddy's Laboratories (RDY), Sarepta Therapeutics (SRPT) and Agios Pharmaceuticals (AGIO).

Who are Perrigo's key executives?

Perrigo's management team includes the folowing people:

Mr. Todd W. Kingma, Exec. VP, Gen. Counsel & Sec. (Age 58)
Mr. Jeffrey R. Needham, Exec. VP & Pres of Consumer Healthcare Americas (Age 62)
Mr. John T. Hendrickson, Exec. (Age 55)
Mr. Uwe Röhrhoff, Pres & CEO (Age 56)
Mr. Ronald L. Winowiecki, Chief Financial Officer (Age 52)

Has Perrigo been receiving favorable news coverage?

Media headlines about PRGO stock have been trending somewhat negative on Thursday, according to Accern. The research firm ranks the sentiment of news coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Perrigo earned a coverage optimism score of -0.03 on Accern's scale. They also assigned media headlines about the company an impact score of 47.01 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the near future.

How do I buy shares of Perrigo?

Shares of PRGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Perrigo's stock price today?

One share of PRGO stock can currently be purchased for approximately $82.68.

How big of a company is Perrigo?

Perrigo has a market capitalization of $11.62 billion and generates $4.95 billion in revenue each year. The company earns $119.60 million in net income (profit) each year or $4.93 on an earnings per share basis. Perrigo employs 10,400 workers across the globe.

How can I contact Perrigo?

Perrigo's mailing address is TREASURY BUILDING LOWER GRAND CANAL STREET, DUBLIN L2, 49010. The company can be reached via phone at 353-1709-4000 or via email at [email protected]

MarketBeat Community Rating for Perrigo (PRGO)

Community Ranking:		2.6 out of 5 ( )
Outperform Votes:		552 (Thanks for Voting!)
Underperform Votes:		514 (Thanks for Voting!)
Total Votes:		1,066

MarketBeat's community ratings are surveys of what our community members think about Perrigo and other stocks. Vote "Outperform" if you believe PRGO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PRGO will underperform the S&P 500 over the long term. You may vote once every thirty days.

Perrigo (NYSE:PRGO) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

18 Wall Street analysts have issued ratings and price targets for Perrigo in the last 12 months. Their average twelve-month price target is $91.8824, suggesting that the stock has a possible upside of 11.08%. The high price target for PRGO is $117.00 and the low price target for PRGO is $67.00. There are currently 9 hold ratings and 9 buy ratings for the stock, resulting in a consensus rating of "Buy."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Buy	Buy	Buy	Hold
Consensus Rating Score:	2.50	2.50	2.53	2.44
Ratings Breakdown:	0 Sell Rating(s) 9 Hold Rating(s) 9 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 9 Hold Rating(s) 9 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 8 Hold Rating(s) 9 Buy Rating(s) 0 Strong Buy Rating(s)	1 Sell Rating(s) 7 Hold Rating(s) 8 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$91.8824	$91.8824	$92.00	$88.50
Price Target Upside:	11.08% upside	6.67% upside	0.34% upside	1.11% upside

Perrigo (NYSE:PRGO) Consensus Price Target History

Price Target History for Perrigo (NYSE:PRGO)

Perrigo (NYSE:PRGO) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
4/16/2018	Canaccord Genuity	Set Price Target	Buy	$105.00	Low
3/5/2018	Oppenheimer	Set Price Target	Buy	$98.00	Low
3/5/2018	JPMorgan Chase	Reiterated Rating	Neutral -> Neutral	$82.00 -> $83.00	Low
3/1/2018	Cantor Fitzgerald	Set Price Target	Buy	$107.00	High
2/1/2018	Berenberg Bank	Initiated Coverage	Buy	$117.00	Low
1/2/2018	Leerink Swann	Initiated Coverage	Mkt Perform -> Market Perform	$90.00	Low
12/8/2017	Argus	Upgrade	Hold -> Buy	$93.00	Medium
12/4/2017	Barclays	Boost Price Target	Overweight	$93.00	Medium
11/10/2017	Jefferies Group	Reiterated Rating	Hold	$81.00	N/A
11/10/2017	Wells Fargo	Boost Price Target	Market Perform	$90.00	N/A
11/10/2017	Morgan Stanley	Boost Price Target	Equal Weight	$79.00 -> $92.00	N/A
11/10/2017	Royal Bank of Canada	Upgrade	Underperform -> Sector Perform	$64.00 -> $86.00	N/A
10/5/2017	UBS	Reiterated Rating	Buy -> Buy	$84.00 -> $98.00	N/A
9/14/2017	Deutsche Bank	Boost Price Target	Buy	$88.00 -> $95.00	Low
9/7/2017	CIBC	Initiated Coverage	Outperform -> Outperform	$88.00	Low
8/11/2017	Stifel Nicolaus	Reiterated Rating	Hold		Low
8/11/2017	Goldman Sachs	Upgrade	Sell -> Neutral	$66.00 -> $79.00	Medium
4/22/2017	B. Riley	Reiterated Rating	Neutral	$67.00	Medium
2/28/2017	Guggenheim	Reiterated Rating	Buy	$125.00	N/A
11/11/2016	Bank of America	Upgrade	Underperform -> Neutral		N/A
8/11/2016	Northland Securities	Downgrade	Outperform -> Market Perform	$123.00 -> $94.00	N/A
6/17/2016	BTIG Research	Reiterated Rating	Neutral		N/A
6/15/2016	Raymond James	Reiterated Rating	Hold		N/A

(Data available from 4/19/2016 forward)

Perrigo (NYSE:PRGO) Earnings History and Estimates Chart

Earnings by Quarter for Perrigo (NYSE:PRGO)

Perrigo (NYSE:PRGO) Earnings Estimates

2018 EPS Consensus Estimate: $5.33

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	3	$1.13	$1.24	$1.17
Q2 2018	3	$1.23	$1.40	$1.30
Q3 2018	3	$1.24	$1.38	$1.29
Q4 2018	3	$1.47	$1.64	$1.57

Perrigo (NYSE PRGO) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
5/28/2018		$1.16					N/A
3/1/2018	Q4 17	$1.25	$1.28	$1.2623 billion	$1.2830 billion	View	Listen
11/9/2017	Q3 17	$1.11	$1.39	$1.1669 billion	$1.2150 billion	View	N/A
8/10/2017	6/30/2017	$0.94	$1.22	$1.1771 billion	$1.2380 billion	View	N/A
5/30/2017	Q1 17	$0.99	$1.05	$1.1922 billion	$1.1940 billion	View	N/A
5/22/2017	12/31/2016	$1.76	$1.24	$1.3874 billion	$1.3310 billion	View	N/A
11/10/2016	Q316	$1.58	$1.65	$1.28 billion	$1.40 billion	View	N/A
8/10/2016	Q216	$1.98	$1.93	$1.43 billion	$1.48 billion	View	Listen
5/12/2016	Q116	$1.75	$1.75	$1.35 billion	$1.34 billion	View	Listen
2/18/2016	Q415	$1.93	$1.80	$1.46 billion	$1.42 billion	View	Listen
10/22/2015	Q3	$1.73	$1.76	$1.42 billion	$1.34 billion	View	Listen
8/5/2015	Q2	$1.96	$2.18	$1.52 million	$1.53 million	View	N/A
4/21/2015	Q315	$1.78	$1.85	$1.1012 billion	$1.0490 billion	View	N/A
2/5/2015	Q215	$1.79	$1.82	$1.09 billion	$1.07 billion	View	N/A
11/6/2014	Q115	$1.44	$1.40	$997.90 million	$951.50 million	View	N/A
8/14/2014	Q414	$1.55	$1.74	$1.09 billion	$1.14 billion	View	N/A
5/7/2014	Q314	$1.51	$1.31	$1.07 billion	$1,000.00 million	View	N/A
2/6/2014	Q214	$1.59	$1.87	$996.68 million	$979.00 million	View	N/A
10/31/2013	Q114	$1.40	$1.52	$900.10 million	$933.00 million	View	N/A
8/15/2013	Q4 2013	$1.56	$1.57	$999.08 million	$967.20 million	View	N/A
5/7/2013	Q3 2013	$1.44	$1.42	$935.44 million	$919.83 million	View	N/A
2/1/2013	Q2 2013	$1.31	$1.36	$881.84 million	$882.96 million	View	N/A
11/7/2012	Q113	$1.24	$1.27	$825.83 million	$769.80 million	View	N/A
8/16/2012		$1.27	$1.28			View	N/A
5/8/2012		$1.22	$1.41			View	N/A
2/7/2012		$1.15	$1.20			View	N/A
10/27/2011		$1.06	$1.10			View	N/A
8/16/2011		$0.97	$1.02			View	N/A
5/3/2011		$0.97	$1.07			View	N/A
2/1/2011		$0.95	$1.05			View	N/A
11/2/2010	Q3 2010	$0.77	$0.87			View	N/A
8/12/2010	Q2 2010	$0.68	$0.71			View	N/A
4/29/2010	Q1 2010	$0.63	$0.76			View	N/A
2/2/2010	Q4 2009	$0.66	$0.70			View	N/A
11/2/2009	Q3 2009	$0.49	$0.66			View	N/A
8/18/2009	Q2 2009	$0.46	$0.50			View	N/A
5/7/2009	Q1 2009	$0.45	$0.51			View	N/A
2/3/2009	Q4 2008	$0.50	$0.46			View	N/A
11/6/2008	Q3 2008	$0.42	$0.41			View	N/A
8/18/2008	Q2 2008	$0.40	$0.39			View	N/A
5/6/2008	Q1 2008	$0.42	$0.44			View	N/A
2/5/2008	Q4 2007	$0.34	$0.36			View	N/A

(Earnings results data provided by Zacks Investment Research)

Perrigo (NYSE:PRGO) Dividend Information

Perrigo pays an annual dividend of $0.76 per share, with a dividend yield of 0.92%. PRGO's most recent quarterly dividend payment was Tuesday, March 20. The company has grown its dividend for the last 15 consecutive years and is increasing its dividend by an average of 15.10% each year. Perrigo pays out 15.42% of its earnings out as a dividend.

Most Recent Dividend:	3/20/2018
Annual Dividend:	$0.76
Dividend Yield:	0.92%
Dividend Growth:	15.10% (3 Year Average)
Payout Ratio:	15.42% (Trailing 12 Months of Earnings) 14.53% (Based on This Year's Estimates) 13.24% (Based on Next Year's Estimates)
Track Record:	15 Years of Consecutive Dividend Growth
Frequency:	Quarterly Dividend

Dividend Payments by Quarter for Perrigo (NYSE:PRGO)

Perrigo (NYSE:PRGO) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
2/15/2018	quarterly	$0.19	0.91%	3/1/2018	3/2/2018	3/20/2018
11/2/2017	quarterly	$0.16	0.77%	11/30/2017	12/1/2017	12/19/2017
8/8/2017	Quarterly	$0.16	0.96%	8/23/2017	8/25/2017	9/12/2017
5/3/2017	quarterly	$0.16	0.88%	5/24/2017	5/26/2017	6/13/2017
2/21/2017	quarterly	$0.16	0.76%	3/1/2017	3/3/2017	3/21/2017
11/8/2016	quarterly	$0.1450	0.69%	11/22/2016	11/25/2016	12/13/2016
8/2/2016	quarterly	$0.1450	0.62%	8/24/2016	8/26/2016	9/13/2016
4/26/2016		$0.1450		5/25/2016	5/27/2016	6/14/2016
4/26/2016	quarterly	$0.1450		5/25/2016	5/27/2016	6/14/2016
2/16/2016	quarterly	$0.1450		2/24/2016	2/26/2016	3/15/2016
11/4/2015	quarterly	$0.1250		11/24/2015	11/27/2015	12/15/2015
8/12/2015	quarterly	$0.1250		8/26/2015	8/28/2015	9/15/2015
4/29/2015	quarterly	$0.1250	0.27%	5/27/2015	5/29/2015	6/16/2015
1/27/2015	quarterly	$0.1250		2/25/2015	2/27/2015	3/17/2015
11/3/2014	quarterly	$0.1050	0.26%	11/27/2014	11/28/2014	12/16/2014
8/13/2014	quarterly	$0.1050	0.28%	8/27/2014	8/29/2014	9/16/2014
4/28/2014	quarterly	$0.1050	0.29%	5/28/2014	5/30/2014	6/17/2014
1/29/2014	quarterly	$0.1050	0.27%	2/26/2014	2/28/2014	3/18/2014
11/6/2013	quarterly	$0.09	0.25%	11/26/2013	11/29/2013	12/17/2013
8/14/2013	quarterly	$0.09	0.29%	8/28/2013	8/30/2013	9/17/2013
5/2/2013	quarterly	$0.09	0.3%	5/29/2013	5/31/2013	6/18/2013
1/31/2013	quarterly	$0.09	0.34%	2/27/2013	3/1/2013	3/19/2013

(Data available from 1/1/2013 forward)

Perrigo (NYSE PRGO) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 6.90%
Institutional Ownership Percentage: 79.16%

Insider Trading History for Perrigo (NYSE:PRGO)

Institutional Ownership by Quarter for Perrigo (NYSE:PRGO)

Perrigo (NYSE PRGO) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/5/2018	Uwe Roehrhoff	CEO	Buy	7,500	$81.85	$613,875.00	4,900
12/28/2017	Todd W Kingma	VP	Sell	1,500	$88.52	$132,780.00	19,565
12/28/2017	Todd W Kingma	VP	Sell	1,500	$88.52	$132,780.00	19,565
12/14/2017	John Wesolowski	EVP	Buy	700	$85.80	$60,060.00
12/7/2017	John Wesolowski	EVP	Sell	450	$83.09	$37,390.50
11/29/2017	John Wesolowski	EVP	Sell	388	$87.20	$33,833.60	248
11/16/2017	Thomas Farrington	EVP	Sell	213	$87.26	$18,586.38	3,347
9/12/2017	Jeffrey Needham	EVP	Sell	3,595	$89.49	$321,716.55	10,118
9/7/2017	Sharon Kochan	EVP	Sell	318	$81.36	$25,872.48	10,231
8/31/2017	Sharon Kochan	EVP	Sell	1,500	$79.03	$118,545.00	10,349
8/30/2017	Thomas Farrington	EVP	Sell	616	$76.90	$47,370.40	2,724
8/18/2017	Thomas Farrington	EVP	Sell	865	$78.40	$67,816.00	2,870
11/25/2016	Judy L Brown	EVP	Sell	2,097	$89.44	$187,555.68	10,007
11/21/2016	Geoffrey M Parker	Director	Buy	2,500	$88.75	$221,875.00
10/24/2016	Judy L Brown	EVP	Sell	2,092	$90.42	$189,158.64	12,104
9/26/2016	Judy L Brown	CFO	Sell	2,096	$96.76	$202,808.96	14,196
9/26/2016	Thomas Farrington	EVP	Sell	1,110	$96.76	$107,403.60	2,970
9/9/2016	Gary K Kunkle Jr	Director	Sell	5,814	$89.95	$522,969.30	31,501
9/8/2016	Herman Morris Jr	Director	Sell	1,073	$90.96	$97,600.08	10,425
8/26/2016	Judy L Brown	EVP	Sell	2,095	$88.28	$184,946.60	16,292
4/13/2016	Judy L Brown	CFO	Sell	2,776	$126.22	$350,386.72	13,924
3/18/2016	Michael J Jandernoa	Director	Sell	761	$128.29	$97,628.69	8,611
3/2/2016	Sharon Kochan	EVP	Sell	1,490	$125.28	$186,667.20	5,883
2/24/2016	Judy L Brown	CFO	Sell	2,776	$123.73	$343,474.48	13,924
1/6/2016	Judy L. Brown	CFO	Sell	27,737	$142.41	$3,950,026.17	12,429
12/28/2015	Joseph C. Papa	Chairman	Sell	10,183	$147.07	$1,497,613.81	118,515
8/25/2015	John T. Hendrickson	EVP	Sell	1,737	$181.37	$315,039.69
8/25/2015	Todd W. Kingma	VP	Sell	1,715	$181.37	$311,049.55	10,320
8/24/2015	John T. Hendrickson	EVP	Sell	4,468	$177.68	$793,874.24	1,737
4/29/2015	Todd W Kingma	VP	Sell	1,700	$190.27	$323,459.00
4/14/2015	John T Hendrickson	EVP	Sell	8,800	$200.27	$1,762,376.00
4/13/2015	Todd W Kingma	VP	Sell	1,300	$198.44	$257,972.00
3/13/2015	Jatin Shah	SVP	Sell	2,000	$165.50	$331,000.00
10/1/2014	Judy L Brown	CFO	Sell	3,515	$150.72	$529,780.80
9/3/2014	Sharon Kochan	EVP	Sell	1,116	$150.00	$167,400.00
9/3/2014	Todd W Kingma	VP	Sell	2,250	$149.65	$336,712.50
9/2/2014	Judy L Brown	CFO	Sell	3,515	$149.32	$524,859.80
9/2/2014	Thomas Farrington	VP	Sell	1,741	$150.36	$261,776.76
8/27/2014	Michael Robert Stewart	VP	Sell	4,519	$148.78	$672,336.82
8/26/2014	Jeffrey Needham	VP	Sell	10,205	$148.54	$1,515,850.70
8/26/2014	Judy L Brown	CFO	Sell	4,827	$148.87	$718,595.49
8/25/2014	John T Hendrickson	EVP	Sell	2,533	$148.44	$375,998.52
5/15/2014	Ran Gottfried	Director	Sell	1,000	$131.25	$131,250.00	12,159
3/24/2014	Joseph Papa	Chairman	Sell	10,000	$157.72	$1,577,200.00	95,500
1/16/2014	Joseph Papa	Chairman	Sell	5,000	$157.59	$787,950.00	96,655
12/12/2013	Gary Cohen	Director	Sell	4,632	$152.52	$706,472.64	11,868
12/12/2013	Joseph Papa	Chairman	Sell	15,000	$150.12	$2,251,800.00	96,655
12/9/2013	Michael Jandernoa	Director	Sell	128,620	$155.30	$19,974,686.00	868
11/25/2013	Louis Yu	VP	Sell	2,292	$155.51	$356,428.92	8,548
11/21/2013	Judy Brown	CFO	Sell	9,988	$154.74	$1,545,543.12	7,445
11/20/2013	John Hendrickson	EVP	Sell	8,400	$152.80	$1,283,520.00
11/4/2013	Ran Gottfried	Director	Sell	2,275	$143.36	$326,144.00	11,609
9/24/2013	Joseph Papa	Chairman	Sell	15,000	$124.60	$1,869,000.00	116,655
9/18/2013	John Hendrickson	EVP	Sell	2,161	$125.00	$270,125.00
9/11/2013	Michael Robert Stewart	VP	Sell	5,063	$123.37	$624,622.31
9/9/2013	Louis Yu	VP	Sell	1,852	$124.11	$229,851.72
9/6/2013	John T Hendrickson	EVP	Sell	1,000	$123.46	$123,460.00
9/4/2013	John T Hendrickson	EVP	Sell	2,000	$123.92	$247,840.00
9/3/2013	Judy Brown	CFO	Sell	2,500	$122.07	$305,175.00	17,433
8/30/2013	Jeffrey Needham	VP	Sell	6,585	$120.47	$793,294.95	5,199
8/29/2013	Sharon Kochan	VP	Sell	3,467	$120.98	$419,437.66	5,541
8/27/2013	Joseph Papa	Chairman	Sell	15,000	$117.64	$1,764,600.00	118,455
8/26/2013	John Hendrickson	EVP	Sell	2,099	$119.15	$250,095.85
8/26/2013	Judy Brown	CFO	Sell	3,424	$119.28	$408,414.72	17,433
8/20/2013	John Hendrickson	EVP	Sell	1,676	$118.56	$198,706.56
8/20/2013	Judy Brown	CFO	Sell	2,804	$118.58	$332,498.32	17,433
8/20/2013	Thomas Farrington	VP	Sell	1,658	$119.86	$198,727.88	1,040
8/16/2013	Todd Kingma	VP	Sell	1,250	$120.00	$150,000.00	17,065
7/19/2013	Todd W Kingma	VP	Sell	1,250	$129.37	$161,712.50
7/11/2013	Joseph C Papa	Chairman	Sell	10,000	$128.54	$1,285,400.00
7/9/2013	John T Hendrickson	EVP	Sell	2,161	$125.00	$270,125.00
6/14/2013	Joseph C Papa	Chairman	Sell	10,000	$118.39	$1,183,900.00
6/14/2013	Todd W Kingma	VP	Sell	1,250	$118.00	$147,500.00
6/4/2013	Judy L Brown	CFO	Sell	2,500	$116.38	$290,950.00
5/14/2013	Sharon Kochan	VP	Sell	2,647	$119.64	$316,687.08	5,492

(Data available from 1/1/2013 forward)

Perrigo (NYSE PRGO) News Headlines

Source:

Date	Headline
	Perrigo (PRGO) Given Average Recommendation of "Hold" by Brokerages www.americanbankingnews.com - April 18 at 11:14 AM
	Q1 2018 EPS Estimates for Perrigo (PRGO) Lifted by Leerink Swann www.americanbankingnews.com - April 18 at 7:52 AM
	Perrigo to Post FY2020 Earnings of $5.65 Per Share, Leerink Swann Forecasts (PRGO) www.americanbankingnews.com - April 17 at 7:05 AM
	Perrigo (PRGO) Given a $105.00 Price Target by Canaccord Genuity Analysts www.americanbankingnews.com - April 16 at 12:05 PM
	BidaskClub Lowers Perrigo (PRGO) to Sell www.americanbankingnews.com - April 14 at 9:51 PM
	BRIEF-Perrigo Launches Novel Omeprazole Orally Disintegrating Tablet to Treat Frequent Heartburn www.reuters.com - April 13 at 8:54 AM
	Free Post Earnings Research Report: Perrigo Co.'s Quarterly Earnings Increased 3.23% finance.yahoo.com - April 13 at 8:54 AM
	Perrigo (PRGO) Downgraded by BidaskClub www.americanbankingnews.com - April 11 at 8:59 PM
	Perrigo Launches Novel Omeprazole Orally Disintegrating Tablet to Treat Frequent Heartburn finance.yahoo.com - April 11 at 5:08 PM
	Perrigo (PRGO) Expected to Announce Quarterly Sales of $1.21 Billion www.americanbankingnews.com - April 10 at 2:36 AM
	$1.14 Earnings Per Share Expected for Perrigo (PRGO) This Quarter www.americanbankingnews.com - April 8 at 5:18 PM
	BidaskClub Downgrades Perrigo (PRGO) to Sell www.americanbankingnews.com - April 4 at 11:58 PM
	Is Perrigo Company plc (NYSE:PRGO) A Sell At Its Current PE Ratio? finance.yahoo.com - April 4 at 3:52 PM
	Why Is Perrigo Company (PRGO) Up 4.7% Since Its Last Earnings Report? finance.yahoo.com - April 2 at 9:08 AM
	Perrigo (PRGO) Stock Rating Reaffirmed by Cantor Fitzgerald www.americanbankingnews.com - March 31 at 5:28 PM
	Perrigo (PRGO) PT Set at $100.00 by Canaccord Genuity www.americanbankingnews.com - March 31 at 2:06 PM
	Head-To-Head Analysis: Perrigo (PRGO) vs. Its Competitors www.americanbankingnews.com - March 30 at 11:23 AM
	Perrigo (PRGO) Stock Rating Reaffirmed by Canaccord Genuity www.americanbankingnews.com - March 27 at 10:22 PM
	Perrigo (PRGO) Given a $105.00 Price Target at Canaccord Genuity www.americanbankingnews.com - March 27 at 9:43 AM
	Perrigo (PRGO) Research Coverage Started at Berenberg Bank www.americanbankingnews.com - March 25 at 9:48 PM
	Perrigo's (PRGO) Buy Rating Reiterated at Oppenheimer www.americanbankingnews.com - March 24 at 8:55 PM
	Canaccord Genuity Reiterates $105.00 Price Target for Perrigo (PRGO) www.americanbankingnews.com - March 24 at 5:43 PM
	Perrigo Company plc (PRGO) Given Average Rating of "Hold" by Brokerages www.americanbankingnews.com - March 24 at 2:24 PM
	$1.21 Billion in Sales Expected for Perrigo Company plc (PRGO) This Quarter www.americanbankingnews.com - March 24 at 2:58 AM
	Will Perrigo Company plc (NYSE:PRGO) Continue To Underperform Its Industry? finance.yahoo.com - March 23 at 5:16 PM
	Zacks: Analysts Anticipate Perrigo Company plc (PRGO) to Announce $1.14 Earnings Per Share www.americanbankingnews.com - March 22 at 5:18 PM
	PRGO Crosses Above Key Moving Average Level - Nasdaq www.nasdaq.com - March 22 at 5:15 PM
	Perrigo (PRGO) PT Set at $105.00 by Canaccord Genuity www.americanbankingnews.com - March 18 at 12:26 PM
	Perrigo (PRGO) Announces Final FDA Approval, Planned Launch for Store Brand OTC Equivalent of Mucinex DM ... - StreetInsider.com www.streetinsider.com - March 8 at 6:11 PM
	Uwe Roehrhoff Purchases 7,500 Shares of Perrigo Company plc (PRGO) Stock www.americanbankingnews.com - March 7 at 6:34 PM
	Perrigo (PRGO) Announces Final FDA Approval, Planned Launch for Store Brand OTC Equivalent of Mucinex DM Maximum Strength ER Tablets www.streetinsider.com - March 7 at 6:02 PM
	Perrigo to Present at Upcoming Investor Conferences finance.yahoo.com - March 7 at 6:02 PM
	Perrigo Announces Final FDA Approval and Planned Launch for the Store Brand OTC Equivalent of Mucinex® DM Maximum Strength Extended Release Tablets finance.yahoo.com - March 7 at 6:02 PM
	FY2018 Earnings Estimate for Perrigo Company plc Issued By Jefferies Group (PRGO) www.americanbankingnews.com - March 7 at 11:50 AM
	Analysts Expect Perrigo Company plc (PRGO) Will Announce Quarterly Sales of $1.21 Billion www.americanbankingnews.com - March 7 at 9:36 AM
	Perrigo (PRGO) PT Set at $98.00 by Oppenheimer www.americanbankingnews.com - March 6 at 10:20 PM
	Mackenzie Financial Corp Buys 146,351 Shares of Perrigo Company plc (PRGO) www.americanbankingnews.com - March 6 at 12:08 PM
	Perrigo Company plc (PRGO) to Post FY2018 Earnings of $5.07 Per Share, Cantor Fitzgerald Forecasts www.americanbankingnews.com - March 6 at 10:08 AM
	Perrigo Company's (PRGO) CEO Uwe Roehrhoff on Q4 2017 Results - Earnings Call Transcript - Seeking Alpha seekingalpha.com - March 6 at 8:40 AM
	Brokers Set Expectations for Perrigo Company plc's Q1 2018 Earnings (PRGO) www.americanbankingnews.com - March 6 at 5:48 AM
	Perrigo (PRGO) Price Target Raised to $83.00 www.americanbankingnews.com - March 5 at 3:04 PM
	Perrigo Company plc (PRGO) Expected to Announce Earnings of $1.21 Per Share www.americanbankingnews.com - March 5 at 1:18 PM
	Quinn Opportunity Partners LLC Sells 1,100 Shares of Perrigo Company plc (PRGO) www.americanbankingnews.com - March 5 at 12:34 PM
	Perrigo Company's (PRGO) CEO (name) on Q4 2017 Results - Earnings Call Transcript - Seeking Alpha seekingalpha.com - March 4 at 6:05 PM
	Continental Advisors LLC Has $5.08 Million Holdings in Perrigo Company plc (PRGO) www.americanbankingnews.com - March 4 at 5:30 AM
	American International Group Inc. Has $4.99 Million Holdings in Perrigo Company plc (PRGO) www.americanbankingnews.com - March 4 at 4:24 AM
	Perrigo Company Enters Oversold Territory - Nasdaq.com - Nasdaq www.nasdaq.com - March 3 at 5:59 PM
	Perrigo (PRGO) Surpassed Earnings in Q4, Revenues Down Y/Y - Nasdaq www.nasdaq.com - March 3 at 5:59 PM
	Perrigo Company plc Reports Fourth Quarter & Calendar Year 2017 ... - PR Newswire (press release) www.prnewswire.com - March 3 at 5:59 PM
	Perrigo Company plc (PRGO) Stake Lifted by State of Tennessee Treasury Department www.americanbankingnews.com - March 3 at 10:12 AM

Perrigo (NYSE:PRGO) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

Perrigo (NYSE:PRGO) Income Statement, Balance Sheet and Cash Flow Statement

Perrigo (NYSE PRGO) Stock Chart for Thursday, April, 19, 2018

Loading chart…

This page was last updated on 4/19/2018 by MarketBeat.com Staff